1st Quarter - Report — FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC (2025)

Firm

FRESENIUS KABI USA LLC

Client

FRESENIUS KABI USA LLC

Income

—

Expenses

$712,941

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Buy America legislation, tariffs, tax incentives, regulatory barriers to generic and biosimilar launch

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	—
SARAH CHRISTINE D'ORSIE	—
STEVEN CHASE WALKER	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Tariff (miscellaneous tariff bills) TAR

Section 232 investigation into pharmaceuticals and unfair trade practices

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	—
SARAH CHRISTINE D'ORSIE	—
STEVEN CHASE WALKER	—

Contacted: Executive Office of the President (EOP); SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Sec. 232 investigation on pharmaceutical sector, tariffs, made in America

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE; White House Office; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Pharmacy PHA

PBM reform, including spread pricing, AWP policy, ASP policy

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

PBM reform, patent reform, ASP reform, international reference pricing, IRA Medicare negotiation, inflation penalty

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

BEAT, AMT, U.S. manufacturing incentives

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Health Issues HCR

Drug pricing, PBM Reform, patent reform, biosimilars, generics, medical devices, FDA approvals, DEHP

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	—
SARAH CHRISTINE D'ORSIE	—
STEVEN CHASE WALKER	—

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.